CME Exam 2: Abnormal TP53 Predicts Risk of Progression in Patients With Q2 Q12 Barrett’s Esophagus Regardless of a Diagnosis of Dysplasia

Posted on December 9, 2021 by Gastroenterology
This entry was posted in News. Bookmark the permalink.